Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;31(13):8891-8899.
doi: 10.1245/s10434-024-16243-3. Epub 2024 Sep 27.

The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer

Mahtab Vasigh  1 , Ahmed Mohamed  1 , Lisa Jacobs  1 , Julie Lange  1 , Melissa Camp  1 , Bonnie Sun  1 , Pamela Wright  1 , Maureen O'Donnell  1 , Hanh-Tam Tran  1 , Olutayo Sogunro  1 , Mehran Habibi  1 , Fabian Johnston  1 , David Euhus  2
Affiliations

The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer

Mahtab Vasigh et al. Ann Surg Oncol. 2024 Dec.

Abstract

Background: Breast-conserving surgery is often discouraged in BRCA gene carriers with early onset breast cancer. The genetic variant carrier breast cancers are more likely to be multifocal or multicentric (MFMC).

Patients and method: This retrospective study includes newly diagnosed patients with breast cancer undergoing genetic testing between 2010 and 2021 within the Johns Hopkins Regional Health System. After excluding patients who received neoadjuvant chemotherapy or stage IV breast cancers, patients were divided into two groups: those who tested positive for a variant recognized by the National Comprehensive Cancer Network as predisposing the patient to breast cancer (ATM, BRCA1, BRCA2, CHEK2, NF1, PALB2, RAD51C, RAD51D, and TP53) and those who tested negative. Pathologic features of the tumors were compared, focusing on evidence for MFMC disease, defined as more than one malignant foci more than 5 mm apart.

Results: Among the 282 eligible cases, 69 (24%) were positive for a genetic variant. The variant carriers were younger at diagnosis (p < 0.001), more likely to have invasive ductal carcinoma (p = 0.03), more likely to have undergone mastectomy (p = 0.03), and more likely to have a grade 3 cancer (p = 0.003). Variant carriers were not more likely to have MFMC disease (28% vs. 22%, p = 0.4). A positive genetic variant was not a predictor of MFMC within the entire cohort [odds ratio (OR):1.3, 95% confidence interval (CI) 0.6-2.6, p = 0.5).

Conclusion: Genetic variant carrier cancers are not more likely to be MCMF than sporadic cancers.

Keywords: BRCA1; BRCA2; Breast cancer-associated genetic variants; Multifocal multicentric breast cancer.

PubMed Disclaimer

References

    1. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New Engl J Med. 1997;336(20):1401–8. - PubMed - DOI
    1. Begg CB, Haile RW, Borg Å, Malone KE, Concannon P, Thomas DC, et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA. 2008;299(2):194–201. - PubMed - PMC - DOI
    1. Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, et al. A population-based study of genes previously implicated in breast cancer. New Engl J Med. 2021;384(5):440–51. - PubMed - DOI
    1. Consortium BCA. Breast cancer risk genes—association analysis in more than 113,000 women. New Engl J Med. 2021;384(5):428–39. - DOI
    1. Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, et al. A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res. 2003;6:1–10. - DOI

Substances

LinkOut - more resources